Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616577 · ClinicalTrials.gov registry record · NA
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT00616577 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 26 participants.
The verdict
NCT00616577, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Caudal epidural analgesia (caudal block) is used in standard pediatric anesthesia practice. It has been shown to be effective in managing postoperative pain in children undergoing abdominal and infraumbilical surgery (Tobias et al 1994). Furthermore, studies have shown that children receiving caudal blocks have secondary benefits such as lower narcotic and anesthetic requirements, more rapid awakening from general anesthesia, decreased time to discharge home, and fewer pain-related behaviors postoperatively (Conroy et al 1993, Tobias et al 1995, Tobias 1996). This proposed study involves the use of a caudal block in children undergoing elective inguinal herniorrhaphy or orchiopexy to evaluate the role of preemptive analgesia in pediatric pain management. We hypothesize that by inhibiting peripheral pain receptors with a caudal block before the onset of a painful stimulus, we can decrease central nervous system sensitization and reduce postoperative analgesic requirements.
Interventions
- DRUG Ropivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00616577
The ClinicalTrials.gov registry entry for NCT00616577 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ropivacaine is the first listed.
NCT00616577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00616577 about?
NCT00616577 is a clinical study titled "Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine". Caudal epidural analgesia (caudal block) is used in standard pediatric anesthesia practice. It has been shown to be effective in managing postoperative pain in children undergoing abdominal and infraumbilical surgery (Tobias et al 1994). Furthermore, studies have shown that children receiving caudal...
What is the current status of trial NCT00616577?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2007-10. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00616577?
The interventions under investigation include: Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00616577?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.